Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

c-Jun N-terminal kinase phosphorylation is a biomarker of plitidepsin activity.

Muñoz-Alonso MJ, Álvarez E, Guillén-Navarro MJ, Pollán M, Avilés P, Galmarini CM, Muñoz A.

Mar Drugs. 2013 May 21;11(5):1677-92. doi: 10.3390/md11051677.

2.

MYC accelerates p21CIP-induced megakaryocytic differentiation involving early mitosis arrest in leukemia cells.

Muñoz-Alonso MJ, Ceballos L, Bretones G, Frade P, León J, Gandarillas A.

J Cell Physiol. 2012 May;227(5):2069-78. doi: 10.1002/jcp.22935.

PMID:
21769863
3.

The mechanism of action of plitidepsin.

Muñoz-Alonso MJ, González-Santiago L, Martínez T, Losada A, Galmarini CM, Muñoz A.

Curr Opin Investig Drugs. 2009 Jun;10(6):536-42. Review.

PMID:
19513942
4.

Determination of viability of human cartilage allografts by a rapid and quantitative method not requiring cartilage digestion.

López C, Ajenjo N, Muñoz-Alonso MJ, Farde P, León J, Gómez-Cimiano J.

Cell Transplant. 2008;17(7):859-64.

PMID:
19044211
5.

Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cells.

Muñoz-Alonso MJ, González-Santiago L, Zarich N, Martínez T, Alvarez E, Rojas JM, Muñoz A.

J Pharmacol Exp Ther. 2008 Mar;324(3):1093-101. Epub 2007 Dec 18.

PMID:
18089842
6.

Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes.

Ceballos E, Muñoz-Alonso MJ, Berwanger B, Acosta JC, Hernández R, Krause M, Hartmann O, Eilers M, León J.

Oncogene. 2005 Jun 30;24(28):4559-71.

PMID:
15856024
7.

p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells.

Muñoz-Alonso MJ, Acosta JC, Richard C, Delgado MD, Sedivy J, León J.

J Biol Chem. 2005 May 6;280(18):18120-9. Epub 2005 Mar 3.

8.
9.

Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.

Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, Eilers M, Leon J, Larsson LG.

Oncogene. 2003 Jan 23;22(3):351-60.

PMID:
12545156
10.

Karyopherin alpha2: a control step of glucose-sensitive gene expression in hepatic cells.

Guillemain G, Muñoz-Alonso MJ, Cassany A, Loizeau M, Faussat AM, Burnol AF, Leturque A.

Biochem J. 2002 May 15;364(Pt 1):201-9.

Supplemental Content

Loading ...
Support Center